Changes in bone mineral density differ between gonadotrophin‐releasing hormone analogue‐ and surgically castrated men with prostate cancerA prospective, controlled, parallel‐group study

Abstract

We found a more pronounced decrease in BMD in men with metastatic prostate cancer who were treated with surgical castration than in those who were treated with GnRH analogues.